BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

NCT06383013 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

BIOLOGICAL: BB-101

Sponsor

Blue Blood Biotech Corp.